FDA restricts J&J’s COVID-19 vaccine due to blood clot risk

Why do some people get sicker from COVID than others?
5 May 2022
New research confirms that racism in health care settings increases vaccine hesitancy among ethnic minority groups
6 May 2022

FDA restricts J&J’s COVID-19 vaccine due to blood clot risk

U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots.

Comments are closed.